Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A.P. Pharma Clarifies Effective Date of Reverse Stock Split.


REDWOOD CITY Redwood City, city (1990 pop. 66,072), seat of San Mateo co., W Calif., on San Francisco Bay; inc. 1868. Manufactures include commmunications, electrical, electronic, and medical equipment. , Calif. -- A.P. Pharma, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:APPA), a specialty pharmaceutical company, today announced that trading of its shares on the Nasdaq Global Market will reflect the 1-for-4 reverse stock split beginning tomorrow, May 25, 2007.

Previously the company had reported that trading of the company's stock would reflect the reverse split beginning today.

About A.P. Pharma

We are a specialty pharmaceutical company focused on developing pharmaceutical products using our proprietary Biochronomer polymer-based drug delivery technology. Our product development philosophy is based on incorporating approved therapeutics into our proprietary bioerodible drug delivery technology to create controlled release pharmaceuticals to improve treatments for diseases or conditions. Our lead product candidate, APF APF,
n the abbreviation for acidulated phosphate fluoride.
530, is currently in a pivotal Phase 3 clinical trial phase 3 clinical trial Phase 3 study. See Phase study.  for the prevention of acute and delayed onset chemotherapy-induced nausea and vomiting Nausea and Vomiting Definition

Nausea is the sensation of being about to vomit. Vomiting, or emesis, is the expelling of undigested food through the mouth.
, or CINV CINV Chemotherapy Induced Nausea and Vomiting .

Our primary focus is to advance our proprietary Biochronomer technology, consisting of bioerodible polymers designed to release drugs over a defined period. We have completed over 100 in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body.

in vi·vo
adj.
Within a living organism.



in vivo adv.
 and in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment.

in vi·tro
adj.
In an artificial environment outside a living organism.
 studies demonstrating that our Biochronomer technology is potentially applicable to a range of therapeutic areas, including pain management, prevention of nausea and vomiting, control of inflammation and treatment of ophthalmic diseases. We have also completed comprehensive animal and human toxicology studies that have established that our Biochronomer polymers are safe and well tolerated. Furthermore, our Biochronomer technology can be designed to deliver drugs over periods varying from days to several months.

Forward-looking Statements

This news release contains "forward-looking statements" as defined by the Private Securities Reform Act of 1995. These forward-looking statements involve risks and uncertainties including uncertainties associated with the successful closing of the common stock offering, regaining compliance with NASDAQ rules, timely development, approval, launch and acceptance of new products, satisfactory completion of clinical studies, establishment of new corporate alliances, progress in research and development programs and other risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. We caution investors that forward-looking statements reflect our analysis only on their stated date. We do not intend to update them except as required by law.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 24, 2007
Words:347
Previous Article:Caris Diagnostics Announces Opening of Phoenix Laboratory.
Next Article:Attain Technologies Named CA's Premier Partner of the Year for 2006 in North America.
Topics:



Related Articles
Cytel Corporation Announces Reverse Stock Split.
A.P. Pharma to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference.
Ciena Announces One-for-Seven Reverse Stock Split.
Ciena Announces Effectiveness of One-For-Seven Reverse Stock Split.
Primedex Health Systems Announces One-for-Two Reverse Stock Split and Name Change to RadNet, Inc.
Xtreme Oil & Gas, Inc. (Previously XTMG) Announces New Stock Symbol XTOG and Confirms Previous Releases on the One for Five Hundred (1 for 500)...
A.P. Pharma Files Registration Statement for a Common Stock Offering.
Foamex Announces Effective Date for 1-for-4 Reverse Stock Split.
Avalon Oil & Gas, Inc. Announces A Reverse Stock Split.
A.P. Pharma Stockholders Approve Reverse Stock Split.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles